Neuropharmagen trademark for pharmacogenetics SAAS platform

Wed, 01 Apr 2026 08:32:06 +0000
Intellectual Property

USPTO received trademark application TM98671767 for NEUROPHARMAGEN filed by an unspecified applicant on July 29, 2024. The application covers International Class 044 medical services including pharmacogenetic analysis software (SAAS/PAAS), genetic testing and research services, medical diagnostic services, and clinical trial support. The application is filed on an Intent-to-Use basis with a deadline of March 31, 2026.